Overview

Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients

Status:
Unknown status

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to Evaluate the Efficacy and Safety of Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients.

Phase:

Phase 3

Details

Lead Sponsor:

Ventria Bioscience

Collaborator:

National Institute on Aging (NIA)

Treatments:

Anti-Bacterial Agents
Antibiotics, Antitubercular
Lactoferrin